| mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
9e-05 |
| mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
0.0007 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.002 |
| mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
| mRNA |
AMG-706 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.006 |
| mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.007 |
| mRNA |
Panobinostat |
FIMM |
pan-cancer |
AAC |
0.29 |
0.007 |
| mRNA |
Tipifarnib |
FIMM |
pan-cancer |
AAC |
0.32 |
0.007 |